In 2023, Piramal Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Piramal Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Piramal Pharma’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
In 2023, the total operational greenhouse gas (GHG) emissions of Piramal Pharma amounted to 124,249 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Piramal Pharma decreased by 8.65%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
In 2023, the total Scope 1 emissions of Piramal Pharma were 43,277 metric tons of CO₂ equivalent (tCO₂e). a
Since 2021, Piramal Pharma's Scope 1 emissions have increased by 4.54%, reflecting a rising long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2022), Piramal Pharma's Scope 1 emissions decreased by 6.43%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
In 2023, Piramal Pharma reported Scope 2 greenhouse gas (GHG) emissions of 80,972 tCO₂e without specifying the calculation method. a
Since 2021, Piramal Pharma's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Piramal Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a
Compared to the previous year (2022), Piramal Pharma's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Piramal Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a
In 2023, Piramal Pharma reported its Scope 2 emissions using an unspecified methodology. a